Get started
Author

Dorottya Moldvai

Observed name: D. Moldvai
Observed institution: Semmelweis University
ORCID: 0009-0004-7831-6176
Observed ORCID: 0009-0004-7831-6176
OpenAlex ID: A5020826438
The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues
2021 · Anna Sebestyén, Titanilla Dankó, et al. · Cancer and Metastasis Reviews · 46
PDF
3D bioprinting and the revolution in experimental cancer model systems—A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures
2023 · Dániel Sztankovics, Dorottya Moldvai, et al. · Pathology & Oncology Research · 38
PDF
Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting
2022 · Titanilla Dankó, Gábor Petővári, et al. · International Journal of Molecular Sciences · 35
PDF
Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells
2021 · Titanilla Dankó, Gábor Petővári, et al. · International Journal of Molecular Sciences · 27
PDF
Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes
2024 · Beáta-Mária Benkő, Gergő Tóth, et al. · International Journal of Pharmaceutics · 19
Mimicking breast cancer tissue—3D bioprinted models in accurate drug sensitivity tests
2025 · Gábor Petővári, Dorottya Moldvai, et al. · Open Research (University of Surrey) · 9
Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas
2024 · Dorottya Moldvai, Dániel Sztankovics, et al. · British Journal of Cancer · 9
PDF
Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing
2023 · Dániel Sztankovics, Ildikó Krencz, et al. · Scientific Reports · 8
PDF
mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies
2024 · Dániel Sztankovics, Dorottya Moldvai, et al. · Pathology & Oncology Research · 7
PDF
Rictor—A Mediator of Progression and Metastasis in Lung Cancer
2024 · Fatime Szalai, Dániel Sztankovics, et al. · Cancers · 7
PDF
In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma
2022 · Anna Mohás, Ildikó Krencz, et al. · Pathology & Oncology Research · 7
PDF
Comparison of molecular subtype composition between independent sets of primary and brain metastatic small cell lung carcinoma and matched samples
2024 · Dániel Sztankovics, Fatime Szalai, et al. · Lung Cancer · 6
PDF
Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics
2022 · Ildikó Krencz, Enikő Vetlényi, et al. · International Journal of Molecular Sciences · 6
PDF
Increased mTOR activity and RICTOR copy number in small cell lung carcinoma progression
2024 · Dániel Sztankovics, Fatime Szalai, et al. · European Journal of Cell Biology · 2
RICTOR amplification is associated with Rictor membrane staining and does not correlate with PD-L1 expression in lung squamous cell carcinoma
2024 · Ildikó Krencz, Dániel Sztankovics, et al. · Pathology & Oncology Research · 1
PDF
Extracellular Matrix as a Metabolic Niche in Cancer
2022 · Anna Sebestyén, Titanilla Dankó, et al. · Biology of extracellular matrix · 1
CD36 ‐mediated lipid rewiring in the metabolic adaptation of tumour ecosystems
2026 · Anna Sebestyén, Viktória Varga, et al. · FEBS Journal
3D bioprinted in vitro models in cancer metabolism research.
2026 · Zsófia Gábriel, Fatime Szalai, et al. · PubMed
From 2D to 3D Bioprinted In Vitro Breast Cancer Model: A Comparative Study of Proliferation, Tissue Structure, and mTOR Signaling
2026 · Dorottya Moldvai, Gábor Petővári, et al. · MedComm
POU2F3 is a Spatiotemporally Permanent Marker in Small Cell Lung Carcinoma
2025 · Ildikó Krencz, Dániel Sztankovics, et al. · Journal of Thoracic Oncology
EP06.06-08 Comparison of RICTOR FISH and Rictor Immunohistochemistry in Lung Squamous Cell Carcinoma
2023 · A. Khoor, I. Krencz, et al. · Journal of Thoracic Oncology
PDF
[Effects of 3D tissue structure on drug sensitivity - 3D bioprinted tissue mimetic structures in cancer research].
2023 · Dorottya Moldvai, Dániel Sztankovics, et al. · PubMed
[he importance of mTOR hyperactivity and RICTOR amplification, and the associated targeted therapy possibilities in malignant tumours].
2023 · Fatime Szalai, Ildikó Krencz, et al. · PubMed
Works count: 23
Citation count: 228
H-index: 8
I10-index: 5
Year
Topic
Type